Edwards Looks to Pipeline After U.S. Sapien Sales Miss Slightly

Edwards’ U.S. sales for its Sapien transcatheter heart valve were slightly lower sequentially in the third quarter, a factor that will likely “continue to fuel concerns around the barriers to adoption,” Leerink Swann analyst Danielle Antalffy says.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00